Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.98EUR
−95.01 MEUR
52.89 MEUR
70.14 M
About Immatics N.V.
Sector
Industry
CEO
Harpreet Singh-Jasuja
Website
Headquarters
Tuebingen
Employees (FY)
343
Founded
2020
ISIN
NL0015285941
FIGI
BBG00VTXH4Z2
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4A3 is 12.31 EUR — it has increased by 4.50% in the past 24 hours. Watch IMMATICS N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange IMMATICS N.V. stocks are traded under the ticker 4A3.
4A3 stock hasn't changed in a week, the month change is a 13.77% rise, over the last year IMMATICS N.V. has showed a 9.91% increase.
We've gathered analysts' opinions on IMMATICS N.V. future price: according to them, 4A3 price has a max estimate of 18.50 EUR and a min estimate of 14.71 EUR. Watch 4A3 chart and read a more detailed IMMATICS N.V. stock forecast: see what analysts think of IMMATICS N.V. and suggest that you do with its stocks.
4A3 stock is 5.07% volatile and has beta coefficient of 2.08. Track IMMATICS N.V. stock price on the chart and check out the list of the most volatile stocks — is IMMATICS N.V. there?
Today IMMATICS N.V. has the market capitalization of 1.25 B, it has increased by 9.52% over the last week.
Yes, you can track IMMATICS N.V. financials in yearly and quarterly reports right on TradingView.
IMMATICS N.V. is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
4A3 earnings for the last quarter are −0.04 EUR per share, whereas the estimation was −0.20 EUR resulting in a 80.41% surprise. The estimated earnings for the next quarter are −0.28 EUR per share. See more details about IMMATICS N.V. earnings.
IMMATICS N.V. revenue for the last quarter amounts to 30.27 M EUR, despite the estimated figure of 20.45 M EUR. In the next quarter, revenue is expected to reach 13.43 M EUR.
4A3 net income for the last quarter is −3.07 M EUR, while the quarter before that showed −25.48 M EUR of net income which accounts for 87.94% change. Track more IMMATICS N.V. financial stats to get the full picture.
No, 4A3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 16, 2024, the company has 343.00 employees. See our rating of the largest employees — is IMMATICS N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMMATICS N.V. EBITDA is −80.88 M EUR, and current EBITDA margin is −177.10%. See more stats in IMMATICS N.V. financial statements.
Like other stocks, 4A3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMATICS N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMATICS N.V. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMATICS N.V. stock shows the strong buy signal. See more of IMMATICS N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.